HOOKIPA Pharma Inc USD0.0001

Sell:$0.89Buy:$0.89$0.01 (0.57%)

Prices delayed by at least 15 minutes
Sell:$0.89
Buy:$0.89
Change:$0.01 (0.57%)
Deal now
Prices delayed by at least 15 minutes
Sell:$0.89
Buy:$0.89
Change:$0.01 (0.57%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company focused on developing immunotherapeutics based on its proprietary arenavirus platform. The Company’s product candidates are designed to induce specific, robust and durable CD8+ T cells and antibodies to eliminate cancers and serious infectious diseases. Its pipeline includes biological therapies for oncology, targeting human papillomavirus type 16-positive (HPV16+) cancers, KRAS mutated cancers, and other targets. Its two primary programs include HB-700 and Eseba-vec. HB-700 is a multi-KRAS mutant-targeting, investigational immunotherapy for the treatment of KRAS mutated cancers, including lung, colorectal and pancreatic cancers. Eseba-vec is an investigational immunotherapeutic agent in clinical development for the treatment of HPV16+ head and neck cancers.

Key people

Malte Peters
Chief Executive Officer, Director
Terry Coelho
Chief Financial Officer, Executive Vice President, Director
Julie O'Neill
Non-Executive Independent Chairman of the Board
Sean A. Cassidy
Independent Director
David R. Kaufman
Independent Director
Click to see more

Key facts

  • Shares in issue
    9.79m
  • EPIC
    HOOK
  • ISIN
    US43906K2096
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • Market cap
    $10.85m
  • Employees
    82
  • Exchange
    Over The Counter
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview of the company, currency, shares in issue, EPIC, location, exchange, index, website, Data sourced by LSEG. Objective, Costs, Fee Structure, Key facts including Benchmark, Gross gearing are provided by MorningStar.